Richard Newcomb Stillwell bought TNXP once, on Jun 8, 2026

Richard Newcomb Stillwell is a director of Tonix Pharmaceuticals Holding Corp. (TNXP), serving on the company’s Board of Directors and reporting as a corporate insider under the name Stillwell Richard Newcomb.( In May 2026 he received a compensation grant of stock options covering 22,700 shares of Tonix common stock under the company’s 2026 Stock Incentive Plan, reflecting his ongoing service as a director.( Earlier SEC filings and insider-trading records identify him as a director and, at times, a 10% owner of Tonix, confirming his role as an individual insider rather than a corporate entity.(

Stillwell brings nearly four decades of experience in corporate law to Tonix, having spent approximately 38 years at the international law firm Ropes & Gray LLP, where he served as Co-Managing Partner of the Boston office and was the first chair of the firm’s Private Equity Group.( His practice principally involved advising private equity firms on acquisitions and related matters, including numerous transactions in the life science and healthcare sectors, experience that Tonix cites as a key reason for his appointment to the Board effective March 15, 2023.( He holds a J.D., cum laude, from Harvard Law School and an A.B., magna cum laude, from Princeton University, providing a strong legal and academic foundation for his board and advisory work.(

Written by Perplexity from public sources.